ANGPTL8: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Bot: HTTP→HTTPS)
 
imported>CitationCleanerBot
m (Various citation & identifier cleanup, plus AWB genfixes (arxiv version pointless when published))
 
Line 16: Line 16:
The encoded 22 kDa protein contains an [[N-terminal]] secretion signal and two [[coiled-coil]] domains and is a member of the [[Angiopoietin-like proteins|angiopoietin-like (ANGPTL) protein family]]. However, in contrast to other ANGPTL proteins, betatrophin lacks the C-terminal fibrinogen-like domain, and therefore it is an atypical member of the ANGPTL family.<ref name="pmid23261442">{{cite journal | vauthors = Fu Z, Yao F, Abou-Samra AB, Zhang R | title = Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family | journal = Biochemical and Biophysical Research Communications | volume = 430 | issue = 3 | pages = 1126–31 | date = Jan 2013 | pmid = 23261442 | doi = 10.1016/j.bbrc.2012.12.025 }}</ref> It shares with [[ANGPTL4|Angptl4]] and Angptl3 the ability to inhibit the enzyme [[Lipoprotein lipase]] (LPL), and its hepatic overexpression causes elevation of circulating [[Triglyceride]] levels in mice.<ref name="pmid22809513">{{cite journal | vauthors = Zhang R | title = Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels | journal = Biochemical and Biophysical Research Communications | volume = 424 | issue = 4 | pages = 786–92 | date = Aug 2012 | pmid = 22809513 | doi = 10.1016/j.bbrc.2012.07.038 }}</ref> In mice betatrophin is secreted by the liver.<ref name="pmid22809513"/><ref name="pmid22569073">{{cite journal | vauthors = Ren G, Kim JY, Smas CM | title = Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism | journal = American Journal of Physiology. Endocrinology and Metabolism | volume = 303 | issue = 3 | pages = E334-51 | date = Aug 2012 | pmid = 22569073 | doi = 10.1152/ajpendo.00084.2012 | pmc=3423120}}</ref>
The encoded 22 kDa protein contains an [[N-terminal]] secretion signal and two [[coiled-coil]] domains and is a member of the [[Angiopoietin-like proteins|angiopoietin-like (ANGPTL) protein family]]. However, in contrast to other ANGPTL proteins, betatrophin lacks the C-terminal fibrinogen-like domain, and therefore it is an atypical member of the ANGPTL family.<ref name="pmid23261442">{{cite journal | vauthors = Fu Z, Yao F, Abou-Samra AB, Zhang R | title = Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family | journal = Biochemical and Biophysical Research Communications | volume = 430 | issue = 3 | pages = 1126–31 | date = Jan 2013 | pmid = 23261442 | doi = 10.1016/j.bbrc.2012.12.025 }}</ref> It shares with [[ANGPTL4|Angptl4]] and Angptl3 the ability to inhibit the enzyme [[Lipoprotein lipase]] (LPL), and its hepatic overexpression causes elevation of circulating [[Triglyceride]] levels in mice.<ref name="pmid22809513">{{cite journal | vauthors = Zhang R | title = Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels | journal = Biochemical and Biophysical Research Communications | volume = 424 | issue = 4 | pages = 786–92 | date = Aug 2012 | pmid = 22809513 | doi = 10.1016/j.bbrc.2012.07.038 }}</ref> In mice betatrophin is secreted by the liver.<ref name="pmid22809513"/><ref name="pmid22569073">{{cite journal | vauthors = Ren G, Kim JY, Smas CM | title = Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism | journal = American Journal of Physiology. Endocrinology and Metabolism | volume = 303 | issue = 3 | pages = E334-51 | date = Aug 2012 | pmid = 22569073 | doi = 10.1152/ajpendo.00084.2012 | pmc=3423120}}</ref>


Despite having elevated post-heparin plasma LPL activity, mice lacking betatrophin/Angptl8 exhibit markedly decreased uptake of [[Very low-density lipoprotein]]-derived [[fatty acid]]s into white [[adipose tissue]] (WAT).<ref name="pmid240437| 87"/> The defect in fatty acids uptake by WAT in Angptl8-null mice is likely due to the enhanced fatty acids uptake by the heart and skeletal muscle, because of the elevated LPL activity in these two tissues,<ref name="pmid26687026">{{cite journal | vauthors = Fu Z, Abou-Samra AB, Zhang R | title = A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase | journal = Scientific Reports | volume = 5 | pages = 18502 | date = December 2015 | pmid = 26687026 | doi = 10.1038/srep18502 | url = http://www.nature.com/articles/srep18502 | pmc=4685196}}</ref> as suggested by the ANGPTL3-4-8 model.<ref name="PMID 27053679">{{cite journal | vauthors = Zhang R | title = The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking. | journal = Open Biology | volume = 6 | pages = 150272 | date = April 2016 | pmid = 27053679 | doi = 10.1098/rsob.150272 | url = http://rsob.royalsocietypublishing.org/content/6/4/150272.long | pmc=4852456}}</ref>
Despite having elevated post-heparin plasma LPL activity, mice lacking betatrophin/Angptl8 exhibit markedly decreased uptake of [[Very low-density lipoprotein]]-derived [[fatty acid]]s into white [[adipose tissue]] (WAT).<ref name="pmid240437| 87"/> The defect in fatty acids uptake by WAT in Angptl8-null mice is likely due to the enhanced fatty acids uptake by the heart and skeletal muscle, because of the elevated LPL activity in these two tissues,<ref name="pmid26687026">{{cite journal | vauthors = Fu Z, Abou-Samra AB, Zhang R | title = A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase | journal = Scientific Reports | volume = 5 | pages = 18502 | date = December 2015 | pmid = 26687026 | doi = 10.1038/srep18502 | url = http://www.nature.com/articles/srep18502 | pmc=4685196}}</ref> as suggested by the ANGPTL3-4-8 model.<ref name=" {{PMID|27053679}}">{{cite journal | vauthors = Zhang R | title = The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking. | journal = Open Biology | volume = 6 | pages = 150272 | date = April 2016 | pmid = 27053679 | doi = 10.1098/rsob.150272 | url = http://rsob.royalsocietypublishing.org/content/6/4/150272.long | pmc=4852456}}</ref>
 
== Structure ==
Three dimensional structure of none of the members of Angiopoietin like proteins (ANGPTLs) is available up till now. However, the structure of ANGPTL8 was predicted  by homology modeling and is also reported in literature.<ref>{{cite journal | vauthors = Siddiqa A, Ahmad J, Ali A, Paracha RZ, Bibi Z, Aslam B | title = Structural characterization of ANGPTL8 (betatrophin) with its interacting partner lipoprotein lipase | journal = Computational Biology and Chemistry | volume = 61 | pages = 210–20 | date = April 2016 | pmid = 26908254 | doi = 10.1016/j.compbiolchem.2016.01.009 }}</ref> It consists of alpha helices and its sequence show high similarity with the coiled-coil domains of [[ANGPTL3]] and [[ANGPTL4]].
 
== Pathway ==
The ANGPTL8 regulatory pathway has been constructed recently by integrating the information of its know transcription factors which is available at WikiPathways data repository with the pathway id '''WP3915'''.<ref>{{cite journal | vauthors = Siddiqa A, Cirillo E, Tareen SH, Ali A, Kutmon M, Eijssen LM, Ahmad J, Evelo CT, Coort SL | title = Visualizing the regulatory role of Angiopoietin-like protein 8 (ANGPTL8) in glucose and lipid metabolic pathways | journal = Genomics | volume = 109 | issue = 5-6 | pages = 408–418 | date = October 2017 | pmid = 28684091 | doi = 10.1016/j.ygeno.2017.06.006 }}</ref>


== Clinical significance ==
== Clinical significance ==
Line 23: Line 29:


== References ==
== References ==
{{Reflist|33em}}
{{Reflist|32em}}


==External links==
==External links==

Latest revision as of 17:13, 7 October 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez

n/a

n/a

Ensembl

n/a

n/a

UniProt

n/a

n/a

RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

ANGPTL8 (also known as lipasin, originally Betatrophin) is a protein that in humans is encoded by the C19orf80 gene.

Gene

The gene for betatrophin lies on mouse chromosome 9 (gene symbol: Gm6484) and on human chromosome 19 (gene symbol: C19orf80).

Discovery

The link between betatrophin and mouse islet cell proliferation was made by Douglas Melton and Peng Yi from Harvard in 2013.[1] However, this link has been quickly proven false by other researchers.[2] In fact, in December 2016 the original paper by Melton and Yi was retracted, putting the link between betatrophin and islets cells to rest. Given the status of betatrophin and taking into account that betatrophin is a member of the angiopoietin-like gene family and shares extensive homology with Angptl4 and Angptl3, the name betatrophin should be abandoned in favor of Angptl8. Other names for betatrophin include TD26, RIFL, and Lipasin.[3]

Function

Betatrophin is a putative peptide hormone found in mice that was proposed to increase the rate at which beta-cells undergo cell division. Injection of mice with betatrophin cDNA lowered blood sugar (i.e. hypoglycemia), presumably due to action at the pancreas. However, treatment of human islets with betatrophin is unable to increase beta-cell division.[4] Furthermore, studies in betatrophin/Angptl8 knock-out mice do not support a role of betatrophin in controlling beta cell growth, yet point to a clear role in regulating plasma triglyceride levels.[5] Based on these studies, it is fairly safe to say that the notion that betatrophin promotes beta cell expansion is dead, which was made official by the retraction of the original paper.[4][6] Deletion of betatrophin/Angptl8 does not seem to impact glucose and insulin tolerance in mice.[7]

The encoded 22 kDa protein contains an N-terminal secretion signal and two coiled-coil domains and is a member of the angiopoietin-like (ANGPTL) protein family. However, in contrast to other ANGPTL proteins, betatrophin lacks the C-terminal fibrinogen-like domain, and therefore it is an atypical member of the ANGPTL family.[8] It shares with Angptl4 and Angptl3 the ability to inhibit the enzyme Lipoprotein lipase (LPL), and its hepatic overexpression causes elevation of circulating Triglyceride levels in mice.[9] In mice betatrophin is secreted by the liver.[9][10]

Despite having elevated post-heparin plasma LPL activity, mice lacking betatrophin/Angptl8 exhibit markedly decreased uptake of Very low-density lipoprotein-derived fatty acids into white adipose tissue (WAT).[7] The defect in fatty acids uptake by WAT in Angptl8-null mice is likely due to the enhanced fatty acids uptake by the heart and skeletal muscle, because of the elevated LPL activity in these two tissues,[11] as suggested by the ANGPTL3-4-8 model.[12]

Structure

Three dimensional structure of none of the members of Angiopoietin like proteins (ANGPTLs) is available up till now. However, the structure of ANGPTL8 was predicted by homology modeling and is also reported in literature.[13] It consists of alpha helices and its sequence show high similarity with the coiled-coil domains of ANGPTL3 and ANGPTL4.

Pathway

The ANGPTL8 regulatory pathway has been constructed recently by integrating the information of its know transcription factors which is available at WikiPathways data repository with the pathway id WP3915.[14]

Clinical significance

It was hoped that betatrophin or its homolog in humans may provide an effective treatment for type 2 diabetes and perhaps even type I diabetes.[1] Unfortunately, since new data have greatly called into question the ability of betatrophin to increase beta-cell replication, its potential use as a therapy for type 2 diabetes is limited.[5] Inhibition of Angptl8 represents a possible therapeutic strategy for hypertriglyceridemia.[11]

References

  1. ↑ 1.0 1.1 Yi P, Park JS, Melton DA (May 2013). "Betatrophin: a hormone that controls pancreatic β cell proliferation". Cell. 153 (4): 747–58. doi:10.1016/j.cell.2013.04.008. PMC 3756510. PMID 23623304.
  2. ↑ Gusarova, Viktoria; Alexa, Corey A.; Na, Erqian; Stevis, Panayiotis E.; Xin, Yurong; Bonner-Weir, Susan; Cohen, Jonathan C.; Hobbs, Helen H.; Murphy, Andrew J. "ANGPTL8/Betatrophin Does Not Control Pancreatic Beta Cell Expansion". Cell. 159 (3): 691–696. doi:10.1016/j.cell.2014.09.027. PMC 4243040. PMID 25417115.
  3. ↑ Zhang R, Abou-Samra AB (Mar 2013). "Emerging roles of Lipasin as a critical lipid regulator". Biochemical and Biophysical Research Communications. 432 (3): 401–5. doi:10.1016/j.bbrc.2013.01.129. PMID 23415864.
  4. ↑ 4.0 4.1 Jiao Y, Le Lay J, Yu M, Naji A, Kaestner KH (Apr 2014). "Elevated mouse hepatic betatrophin expression does not increase human β-cell replication in the transplant setting". Diabetes. 63 (4): 1283–8. doi:10.2337/db13-1435. PMC 3964501. PMID 24353178.
  5. ↑ 5.0 5.1 Gusarova V, Alexa CA, Na E, Stevis PE, Xin Y, Bonner-Weir S, Cohen JC, Hobbs HH, Murphy AJ, Yancopoulos GD, Gromada J (Oct 2014). "ANGPTL8/betatrophin does not control pancreatic beta cell expansion". Cell. 159 (3): 691–6. doi:10.1016/j.cell.2014.09.027. PMC 4243040. PMID 25417115.
  6. ↑ Stewart AF (Apr 2014). "Betatrophin versus bitter-trophin and the elephant in the room: time for a new normal in β-cell regeneration research". Diabetes. 63 (4): 1198–9. doi:10.2337/DB14-0009. PMC 3964499. PMID 24651805.
  7. ↑ 7.0 7.1 Wang Y, Quagliarini F, Gusarova V, Gromada J, Valenzuela DM, Cohen JC, Hobbs HH (Oct 2013). "Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis". Proceedings of the National Academy of Sciences of the United States of America. 110 (40): 16109–14. doi:10.1073/pnas.1315292110. PMC 3791734. PMID 24043787.
  8. ↑ Fu Z, Yao F, Abou-Samra AB, Zhang R (Jan 2013). "Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family". Biochemical and Biophysical Research Communications. 430 (3): 1126–31. doi:10.1016/j.bbrc.2012.12.025. PMID 23261442.
  9. ↑ 9.0 9.1 Zhang R (Aug 2012). "Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels". Biochemical and Biophysical Research Communications. 424 (4): 786–92. doi:10.1016/j.bbrc.2012.07.038. PMID 22809513.
  10. ↑ Ren G, Kim JY, Smas CM (Aug 2012). "Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism". American Journal of Physiology. Endocrinology and Metabolism. 303 (3): E334–51. doi:10.1152/ajpendo.00084.2012. PMC 3423120. PMID 22569073.
  11. ↑ 11.0 11.1 Fu Z, Abou-Samra AB, Zhang R (December 2015). "A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase". Scientific Reports. 5: 18502. doi:10.1038/srep18502. PMC 4685196. PMID 26687026.
  12. ↑ Zhang R (April 2016). "The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking". Open Biology. 6: 150272. doi:10.1098/rsob.150272. PMC 4852456. PMID 27053679.
  13. ↑ Siddiqa A, Ahmad J, Ali A, Paracha RZ, Bibi Z, Aslam B (April 2016). "Structural characterization of ANGPTL8 (betatrophin) with its interacting partner lipoprotein lipase". Computational Biology and Chemistry. 61: 210–20. doi:10.1016/j.compbiolchem.2016.01.009. PMID 26908254.
  14. ↑ Siddiqa A, Cirillo E, Tareen SH, Ali A, Kutmon M, Eijssen LM, Ahmad J, Evelo CT, Coort SL (October 2017). "Visualizing the regulatory role of Angiopoietin-like protein 8 (ANGPTL8) in glucose and lipid metabolic pathways". Genomics. 109 (5–6): 408–418. doi:10.1016/j.ygeno.2017.06.006. PMID 28684091.

External links

Retrieved from "https://www.wikidoc.org/index.php?title=ANGPTL8&oldid=1529639"